Indianapolis-based Eli Lilly and Company announced Monday, Nov. 3 that it plans to build a new $3 billion manufacturing facility in Katwijk, the Netherlands, located within the Leiden Bio Science Park.
Read MoreEli Lilly and Company announced Wednesday, Oct. 29 a planned investment of more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Carolina, Puerto Rico.
Read MoreEli Lilly and Company and Adverum Biotechnologies, a clinical-stage gene therapy company aiming to preserve sight for life in highly prevalent ocular diseases, today announced a definitive agreement for Lilly to acquire Adverum and its lead product candidate, Ixo-vec.
Read MoreIndiana employers are bracing for potential disruption after a recent presidential proclamation created a new annual fee of $100,000 for H-1B visas, sharply increasing the cost for businesses that rely on highly skilled foreign workers.
Read MoreEli Lilly and Co. has reached an agreement with pharmaceutical Cipla to market tirzepatide, the active ingredient in Lilly’s weight loss and Type 2 diabetes treatments, under a separate brand name in Cipla’s home country of India.
Read MoreThe Lilly Center for Lakes & Streams will host three new fall events: a tree identification hike, a seed collecting workshop, and a bird identification event.
Read MoreTrine University has received a grant of more than $400,000 from Lilly Endowment Inc. to sustain and enhance its youth camps and workshops.
Read MoreA new $5 billion Eli Lilly plant in Goochland County is expected to bring 650 permanent jobs and 1,800 construction jobs, making it one of Virginia’s largest manufacturing projects.
Read MoreParkview Health is inviting communities to take part in DNA Insights, a no-cost community health research program designed in partnership with Helix, the leading precision health organization, to help participants better understand their genetic health risks and contribute to the future of personalized medicine.
Read MoreTexas Attorney General Ken Paxton has filed a lawsuit against pharmaceutical giant Eli Lilly for allegedly bribing and illegally inducing medical providers to prescribe its most profitable drugs, including the high-demand GLP-1 medications Mounjaro and Zepbound that are used for weight loss and diabetes treatment.
Read MoreIndianapolis-based Eli Lilly and Co. shares fell Thursday, Aug. 7 following the pharmaceutical company’s second-quarter earnings report, alongside results from a closely watched trial of its experimental weight-loss pill.
Read MoreGovernor Eric J. Holcomb recently joined Eli Lilly and Company Chair and CEO David A. Ricks to announce Lilly’s plans to increase its investment at the LEAP Research and Innovation District in Lebanon.
Read MoreEli Lilly and Company announced today that it has more than doubled its investment in its Lebanon manufacturing site with a new $5.3 billion commitment, increasing the company’s total investment in this site from $3.7 billion to $9 billion.
Read MoreEli Lilly has partnered with Amazon Pharmacy to deliver medicine as part of its service, LillyDirect Pharmacy Solutions.
Read MoreIndiana University Indianapolis and Eli Lilly and Company are launching a new co-op partnership to enhance talent pipelines and expand workforce development opportunities for people in central Indiana.
Read MoreIndianapolis-based drugmaker Eli Lilly reportedly agreed May 26 to pay $13.5 million to settle a class-action lawsuit alleging the company has for years overpriced insulin products.
Read More
